The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727 · cited 2×
“Numerous apoptotic signals such as TNF-a, ionizing radiations and chemotherapeutic drugs have been shown to induce NF-kB (Pahl, 1999).”
BackgroundActivators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., & Baltimore, D. (1995) · Nature · doi:10.1038/376167a0 · Cited by 1,825
Expression of Multidrug Resistance Gene in Human Cancers
Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S.-L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., et al. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.2.116 · Cited by 1,290
The sphingomyelin cycle and the second messenger function of ceramide.
Hannun, Y. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41834-5 · Cited by 1,235
Control of apoptosis by Rel/NF-κB transcription factors
Barkett, M., & Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203238 · Cited by 1,204
How NF-κB is activated: the role of the IκB kinase (IKK) complex
Karin, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203219 · Cited by 1,156
Aberrant rel/nfkb genes and activity in human cancer
Rayet, B., & Gélinas, C. (1999) · Oncogene · doi:10.1038/sj.onc.1203221 · Cited by 1,110
Ray, A., & Prefontaine, K. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.752 · Cited by 1,064
Gros, P., Croop, J., & Housman, D. (1986) · Cell · doi:10.1016/0092-8674(86)90594-5 · Cited by 1,031
Wang, C.-Y., Cusack, J. C., Liu, R., & Baldwin, A. S. (1999) · Nature Medicine · doi:10.1038/7410 · Cited by 988
Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene
Li, Q., Antwerp, D. V., Mercurio, F., Lee, K.-F., & Verma, I. M. (1999) · Science · doi:10.1126/science.284.5412.321 · Cited by 963
The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling
KOLESNICK, R. (1994) · Cell · doi:10.1016/0092-8674(94)90147-3 · Cited by 920
Scheinman, R. I., Gualberto, A., Jewell, C. M., Cidlowski, J. A., & Baldwin, A. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.943 · Cited by 819
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-448_4 · Cited by 788
Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H. D., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 761
Role of NF-κB in p53-mediated programmed cell death
Ryan, K. M., Ernst, M. K., Rice, N. R., & Vousden, K. H. (2000) · Nature · doi:10.1038/35009130 · Cited by 740
Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A., & Green, D. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80054-4 · Cited by 721
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G. J., Rogers, A. E., Traish, A. M., & Sonenshein, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119848 · Cited by 720
Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells.
Wu, M., Lee, H., Bellas, R. E., Schauer, S. L., Arsura, M., Katz, D., FitzGerald, M. J., Rothstein, T. L., Sherr, D. H., & Sonenshein, G. E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00845.x · Cited by 587
Caldenhoven, E., Liden, J., Wissink, S., Van de Stolpe, A., Raaijmakers, J., Koenderman, L., Okret, S., Gustafsson, J. A., & Van der Saag, P. T. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.4.7659084 · Cited by 489
Smyth, M. J., Krasovskis, E., Sutton, V. R., & Johnstone, R. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.7024 · Cited by 356
Johnstone, R. W., Cretney, E., & Smyth, M. J. (1999) · Blood · doi:10.1182/blood.v93.3.1075 · Cited by 315
Thévenod, F., Friedmann, J. M., Katsen, A. D., & Hauser, I. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1887 · Cited by 301
Bours, V, Burd, P. R., Brown, K., Villalobos, J., Park, S., Ryseck, R. P., Bravo, R., Kelly, K., & Siebenlist, U. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.2.685 · Cited by 269
Self-citationMutant p53 Cooperates with ETS and Selectively Up-regulates Human MDR1 Not MRP1
Sampath, J., Sun, D., Kidd, V. J., Grenet, J., Gandhi, A., Shapiro, L. H., Wang, Q., Zambetti, G. P., & Schuetz, J. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103429200 · Cited by 244 · cited 1×
“…of the mdr1 is controlled by numerous transcription factors, such as SP1, NF-Y, YB1, MEF1 (MDR1 promoter-enhancing factor1), p53 and NF-R1 (Ogura et al., 1992; Madden et al., 1993; Sundseth et al., 1997; Ohga et al., 1998; Hu et al., 2000; Ogretmen and Safa, 2000; Sampath et al., 2001).”
BackgroundOhga, T., Uchiumi, T., Makino, Y., Koike, K., Wada, M., Kuwano, M., & Kohno, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.5997 · Cited by 233
Nuclear factor-κB, cancer, and apoptosis
Bours, V., Bentires-Alj, M., Hellin, A.-C., Viatour, P., Robe, P., Delhalle, S., Benoit, V., & Merville, M.-P. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00391-9 · Cited by 211
Self-citationNF-κB-mediated Induction of mdr1b Expression by Insulin in Rat Hepatoma Cells
Zhou, G., & Kuo, M. T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15174 · Cited by 193
Kuo, M. T., Liu, Z., Wei, Y., Lin-Lee, Y.-C., Tatebe, S., Mills, G. B., & Unate, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205117 · Cited by 193
Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF‐κB activation
Meyer, S., Kohler, N. G., & Joly, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00930-7 · Cited by 161
Transcriptional Activation of the MDR1 Gene by UV Irradiation
Hu, Z., Jin, S. V., & Scotto, K. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2979 · Cited by 146
Ceramide: a novel second messenger
Kolesnick, R. (1992) · Trends in Cell Biology · doi:10.1016/0962-8924(92)90310-j · Cited by 136
Lee, J.-I., Ganster, R. W., Geller, D. A., Burckart, G. J., Thomson, A. W., & Lü, L. (1999) · Transplantation · doi:10.1097/00007890-199911150-00007 · Cited by 124
Bezombes, C., Maestre, N., Laurent, G., Levade, T., Bettaïeb, A., & Jaffrézou, J. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.1.101 · Cited by 123
Madden, M., Morrow, C. S., Nakagawa, M., Goldsmith, M. E., Fairchild, C. R., & Cowan, K. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53095-7 · Cited by 96
Öğretmen, B., & Safa, A. R. (1999) · Biochemistry · doi:10.1021/bi982236+ · Cited by 86
DNA Elements Recognizing NF-Y and Sp1 Regulate the Human Multidrug-Resistance Gene Promoter
Sundseth, R., MacDonald, G. H., Ting, J. P. ‐., & King, A. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.6.963 · Cited by 85
Marienfeld, R. B., Neumann, M., Chuvpilo, S. A., Escher, C., Kneitz, B., Avots, A., Schimpl, A., & Serfling, E. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270703 · Cited by 77
Bonizzi, G., Dejardin, E., Piret, B., Piette, J. G., Merville, M., & Bours, V. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0544r.x · Cited by 74
Self-citationRos, J. E., Schuetz, J. D., Geuken, M., Streetz, K. L., Moshage, H. J., Kuipers, F., Manns, M. P., Jansen, P. L. M., Trautwein, C., & Müller, M. M. (2001) · Hepatology · doi:10.1053/jhep.2001.24667 · Cited by 69
Schmidt, A. G., Hennighausen, L. G., & Siebenlist, U. K. (1990) · Journal of Virology · doi:10.1128/jvi.64.8.4037-4041.1990 · Cited by 63
Öğretmen, B., & Safa, A. R. (1999) · Biochemistry · doi:10.1021/bi991943f · Cited by 49
Um, J. H., Kang, C., Lee, B. G., Kim, D. W., Chung, B., & Kim, S. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204732 · Cited by 47
Ogura, M., Takatori, T., & Tsuruo, T. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.21.5811 · Cited by 34
Cited by
The proteasome: a suitable antineoplastic target
Adams, J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1361 · Cited by 1,201
Nanomedicine therapeutic approaches to overcome cancer drug resistance
Markman, J. L., Rekechenetskiy, A., Holler, E., & Ljubimova, J. Y. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.019 · Cited by 733
“Further, the anti-apoptotic, pro-survival regulator Bcl-2 [31] and nuclear factor kappa B (NF-κB), a transcription factor that controls genes that suppress apoptotic responses [32], are frequently overexpressed in cancer cells and lead to increased survival.”
BackgroundNuclear factor-κB inhibitors as sensitizers to anticancer drugs
Nakanishi, C., & Toi, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1588 · Cited by 724
Li, W., Zhang, H., Assaraf, Y. G., Zhao, K., Xu, X., Xie, J., Yang, D.-H., & Chen, Z.-S. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.05.001 · Cited by 673
Understanding and targeting cancer stem cells: therapeutic implications and challenges
Chen, K., Huang, Y.-H., & Chen, J.-L. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.27 · Cited by 608
Metadata
- Authors
- Bentires-Alj, M., Barbu, V., Fillet, M., Chariot, A., Relic, B., Jacobs, N., Gielen, J., Merville, M.-P., & Bours, V.
- Venue
- Oncogene
- Published
- 2003-01-09
- Volume
- 22
- Issue
- 1
- Pages
- 90-97
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2139959086
- Cited by
- 430
- References
- 48
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.